Biolines Weekender is BioNJ’s e-newsletter featuring the latest happenings in R&D, as well as the incredible innovation coming from New Jersey’s robust life sciences ecosystem. Click here to subscribe to our mailing list.

Weekender 10/8/2021

Last week, BioNJ released a new white paper, “Prescription Drug Affordability Boards: Myths vs. Facts on Drug Supply Chain,” that corrects the record on several common myths about Prescription Drug Affordability Boards (PDAB) and their harmful impact on Patients and the medical innovation ecosystem. The BioNJ white paper concludes that policymakers should avoid the creation of a PDAB as a means to control drug costs and should instead adopt solutions that will improve Patient access and deliver savings to the health care system, such as capping Patient out-of-pocket costs and using negotiated rebates to provide savings to Patients.

Weekender 9/24/2021

BioNJ recently released the speaker roster for our Ninth Annual C-Suite Summit,entitled “Transitional to the ‘Next Normal’: Biopharma’s Role in Addressing the COVID-19 Crisis and What’s Next,” taking place virtually Friday, October 15, 2021,from 8:30 a.m.-2:15 p.m. After closely monitoring updates from the Centers for Disease Control and Prevention and State and local health agencies, as well as speaking with leading epidemiologists, BioNJ has decided to present this year’s full-day C-Suite Summit virtually, instead of its originally planned in-person format.

Weekender 9/10/2021

We are excited to announce BioNJ’s new Value of Medical Innovation Blog. In our first edition, Alliance for Patient Access (AfPA) Executive Director Josie Cooper explains how the Institute for Clinical and Economic Review (ICER) undermines the critical relationship between patients and their providers with its “one-size-fits-all” approach to drug value assessment.

Weekender 8/27/2021

As Labor Day approaches, the BioNJ Team has been busy planning for our upcoming events schedule. Whether in-person or virtual, BioNJ is committed to bringing you quality programming featuring informative plenary sessions as well as interactive networking opportunities.

Weekender 8/13/2021

Earlier this week, BioNJ opened registration for our first live (fingers crossed that we do not need to revert to a virtual experience) event of 2021! Please join us on Friday, October 15, for BioNJ’s Ninth Annual C-Suite Summit, where we’ll reflect on this past year’s successes and challenges, discuss the next wave of innovation across the value chain and share thoughts on how the industry can deepen and scale its commitment to delivering a positive impact for society. Click here for the program agenda and growing list of speakers. We are looking forward to seeing you and your colleagues in-person!

Weekender 7/30/2021

As the country — and the nation — continue to navigate the new “norm” in the era of COVID-19, we, at BioNJ, are extremely proud of the unwavering commitment and tireless work being done by the life sciences industry here in New Jersey. The Garden State has gallantly led the way in research for testing, antivirals, therapeutics and vaccines against this devastating virus.

Weekender 7/16/2021

Core to BioNJ’s mission is helping companies find the talent they need to ensure New Jersey’s life sciences ecosystem has the required expertise to drive medical innovation forward. With this in mind, BioNJ’s Talent Services Career Portal was specifically designed to bring together top talent with leading companies in the New Jersey region.

Weekender 6/25/2021

The COVID-19 pandemic necessitated changes in nearly every aspect of our lives. Nowhere was this more apparent than in our health care system. Among the hardest hit states in the early days of the pandemic, New Jersey’s health care system immediately stepped to the plate to treat and triage COVID-19 Patients. Additionally, the Garden State’s vibrant life sciences ecosystem delivered unprecedented innovation — from providers and others adapting to a new and unknown virus to the ongoing research and development of vaccines and treatments that have played a major factor in our return to “normal.”

Weekender 6/11/2021

As the world continues to navigate the “new” norm, it has never been more important for the life sciences community to come together and support and learn from one another. BioNJ is dedicated to working hard on behalf of our Members — while you are hard at work for Patients. Make sure to take advantage of all the value-driven opportunities available to your organization through your BioNJ Membership.

Weekender 5/28/2021

Thank you to everyone who joined us last week for BioNJ’s 11th Annual BioPartnering Conference. Presented in concert with J.P. Morgan and Johnson & Johnson Innovation on May 18 and 19, the Conference brought together life sciences professionals from 9 countries and 20 states as well as the District of Columbia and featured nearly 70 company and pitch presentations, hundreds of 1:1 partnering meetings and plenary sessions led by industry leaders and world-renowned research institutions from the region.

Weekender 5/14/2021

We hope to see you next week at BioNJ’s Virtual BioPartnering Conference, developed and presented in concert with J.P. Morgan and Johnson & Johnson Innovation. Taking place May 18 and 19, BioNJ’s BioPartnering Conference is a unique opportunity to connect with life sciences executives, investors, institutional collaborators and business development professionals; schedule 1:1 meetings with potential partners; present and watch Company and Start-up Pitch Presentations; hear from industry experts; discuss business and research opportunities with world-renowned institutions and network directly with other conference attendees. Click here for a list of topics and speakers.

Weekender 4/30/2021

COVID-19 has exposed just how vulnerable so many communities are in the face of disease and just how critical access to necessary treatment is to protecting and maintaining patient health. The pandemic has also exposed how deep health inequities continue to leave many underserved communities behind. Unfortunately, lawmakers are increasingly looking to the Institute for Clinical and Economic Review (ICER) and drug value assessment frameworks for how to accurately price new and innovative medical treatments — many of which are being developed by life sciences companies that call New Jersey home. ICER uses the “Quality Adjusted Life Years” (QALY) methodology to determine the value of new drugs and then issues reports on these therapies when they come to the market.

Weekender 4/16/2021

The COVID-19 pandemic has necessitated changes in nearly every aspect of our lives during the last year. Nowhere has this been more apparent than in our health care system. The Coronavirus pandemic has presented an unprecedented challenge to our health care system and had a profound impact on people’s lives and livelihoods.

Weekender 3/19/2021

Thank you to the many companies that have submitted applications to present at this year’s BioNJ’s Virtual BioPartnering Conference, developed and presented in concert with J.P. Morgan and Johnson & Johnson Innovation. Thank you to our partners at JPM and J&JI for their active collaboration, engagement and counsel. It is extraordinary!

Weekender 3/5/2021

Earlier this week we released the agenda and speaker roster for our Inaugural Diversity, Equity & Inclusion…Because It Matters Conference, taking place virtually on March 24 and 25, 2021.

Weekender 2/19/2021

Now that we are one year in and vaccines are a reality, there is so much to think about and plan for! Join us next Thursday, February 25, for BioNJ’s Virtual Briefing where we’ll learn the latest on the vaccine and its variants and hear from those directly in the trenches developing plans for returning to the office and engaging with their Teams through the pandemic. Click here for details.

Weekender 2/5/2021

Thank you to everyone who joined us for yesterday’s BioNJ Board and Member Connection. We were excited to bring our Membership together for this interactive program. During yesterday’s event, BioNJ announced the election of its 2021 Officers and Board Members.

Weekender 1/22/2021

We look forward to seeing our Members on Thursday, February 4 for the first-ever BioNJ Board and Member Connection. This interactive Members-Only program is focused on providing our Members the opportunity to ENGAGE and discuss topics affecting the industry now. We’ll start by welcoming BioNJ’s next Chair of the Board and newest Board Members before hearing presentations by State representatives on New Jersey’s Vaccine Rollout Plan and the newly announced New Jersey Economic Recovery Act.

Weekender 1/8/2021

With the onset of 2021 comes hope and encouragement, as the landmark New Jersey Economic Recovery Act of 2020 was signed into law yesterday by Governor Murphy. The $14.4-billion New Jersey Economic Recovery Act of 2020 features exciting new programs as well as enhancements to existing programs that will result in economic development opportunities for New Jersey while propelling the State’s economic recovery and growth for much of the next decade.